Remi Planes

Dr. Remi Planes

IPBS, CNRS-Université Toulouse III, CNRS Toulouse, France
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in Molecular Cell
Verified
Journal Article
Closed access
RPRemi Planes
Remi Planes
MPMiriam Pinilla
Miriam Pinilla
KSKarin Santoni
Karin Santoni
AHAudrey Hessel
Audrey Hessel
CPCharlotte Passemar
Charlotte Passemar
EMEtienne Meunier
Etienne Meunier

28 July 2022 in EMBO Reports
Verified
Journal Article
Closed access
DCDhruv Chauhan
Dhruv Chauhan
DDDieter Demon
Dieter Demon
LWLieselotte Vande Walle
Lieselotte Vande Walle
OPOonagh Paerewijck
Oonagh Paerewijck
AZAnnalisa Zecchin
Annalisa Zecchin
MLMohamed Lamkanfi
Mohamed Lamkanfi

8 May 2022 in Viruses
Verified
Journal Article
Open access
PDF file
RPRemi Planes
Remi Planes
JBJean-Baptiste Bert
Jean-Baptiste Bert
STSofiane Tairi
Sofiane Tairi
LBLBACHIR BENMOHAMED
LBACHIR BENMOHAMED
Elmostafa BahraouiElmostafa Bahraoui
Elmostafa Bahraoui
This paper presents a molecular characterization of the interaction between the SARS-CoV-2 envelope (E) protein and TLR2. We demonstrated that the E protein, both as a recombinant soluble protein and as a native membrane protein associated with SARS-CoV-2 viral particles, interacts physically with the TLR2 receptor in a specific and dose-dependent manner. Furthermore, we showed that the specific interaction with the TLR2 pathway activates the NF-κB transcription factor and stimulates the production of the CXCL8 inflammatory chemokine. In agreement with the importance of NF-κB in the TLR signaling pathway, we showed that the chemical inhibition of this transcription factor leads to significant inhibition of CXCL8 production, while the blockade of the P38 and ERK1/2 MAP kinases only results in partial CXCL8 inhibition. Overall, our findings propose the envelope (E) protein as a novel molecular target for COVID-19 interventions: either (i) by exploring the therapeutic effect of anti-E blocking/neutralizing antibodies in symptomatic COVID-19 patients, or (ii) as a promising non-spike SARS-CoV-2 antigen candidate for inclusion in the development of next-generation prophylactic vaccines against COVID-19 infection and disease.

18 July 2022 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
KSKarin Santoni
Karin Santoni
DPDavid Pericat
David Pericat
LGLeana Gorse
Leana Gorse
JBJulien Buyck
Julien Buyck
MPMiriam Pinilla
Miriam Pinilla
RPRemi Planes
Remi Planes
Multiple regulated neutrophil cell death programs contribute to host defense against infections. However, despite expressing all necessary inflammasome components, neutrophils are thought to be generally defective in Caspase-1-dependent pyroptosis. By screening different bacterial species, we found that several Pseudomonas aeruginosa (P. aeruginosa) strains trigger Caspase-1-dependent pyroptosis in human and murine neutrophils. Notably, deletion of Exotoxins U or S in P. aeruginosa enhanced neutrophil death to Caspase-1-dependent pyroptosis, suggesting that these exotoxins interfere with this pathway. Mechanistically, P. aeruginosa Flagellin activates the NLRC4 inflammasome, which supports Caspase-1-driven interleukin (IL)-1β secretion and Gasdermin D (GSDMD)-dependent neutrophil pyroptosis. Furthermore, P. aeruginosa-induced GSDMD activation triggers Calcium-dependent and Peptidyl Arginine Deaminase-4-driven histone citrullination and translocation of neutrophil DNA into the cell cytosol without inducing extracellular Neutrophil Extracellular Traps. Finally, we show that neutrophil Caspase-1 contributes to IL-1β production and susceptibility to pyroptosis-inducing P. aeruginosa strains in vivo. Overall, we demonstrate that neutrophils are not universally resistant for Caspase-1-dependent pyroptosis.

7 April 2022 in Autophagy
Verified
Journal Article
Closed access
LDLaure DAVID
Laure DAVID
FTFrederic Taieb
Frederic Taieb
MPMarie Pénary
Marie Pénary
PBPierre-Jean Bordignon
Pierre-Jean Bordignon
RPRemi Planes
Remi Planes
Eric OswaldEric Oswald
Eric Oswald
Escherichia coli strains are responsible for a majority of human extra-intestinal infections, resulting in huge direct medical and social costs. We had previously shown that HlyF encoded by a large virulence plasmid harbored by pathogenic E. coli is not a hemolysin but a cytoplasmic enzyme leading to the overproduction of outer membrane vesicles (OMVs). Here, we showed that these specific OMVs inhibit the macroautophagic/autophagic flux by impairing the autophagosome-lysosome fusion, thus preventing the formation of acidic autolysosomes and autophagosome clearance. Furthermore, HlyF-associated OMVs were more prone to activate the non-canonical inflammasome pathway. Because autophagy and inflammation are crucial in the host’s response to infection especially during sepsis, our findings revealed an unsuspected role of OMVs in the crosstalk between bacteria and their host, highlighting the fact that these extracellular vesicles have exacerbated pathogenic properties. Abbreviations: AIEC: adherent-invasive E. coliBDI: bright detail intensityBMDM: bone marrow‐derived macrophagesCASP: caspaseE. coli: Escherichia coliEHEC: enterohemorrhagic E. coliExPEC: extra-intestinal pathogenic E. coliGSDMD: gasdermin DGFP: green fluorescent proteinHBSS: Hanks’ balanced salt solutionHlyF: hemolysin FIL1B/IL‐1B: interleukin 1 betaISX: ImageStreamX systemLPS: lipopolysaccharideMut: mutatedOMV: outer membrane vesicleRFP: red fluorescent proteinTEM: transmission electron microscopyWT: wild-type

29 August 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MMMiriam Pinilla Marquinez
Miriam Pinilla Marquinez
RMRaoul Mazars
Raoul Mazars
RVRomain Vergé
Romain Vergé
LGLeana Gorse
Leana Gorse
MPMargaux Paradis
Margaux Paradis
EMEtienne Meunier
Etienne Meunier
Human airway and corneal epithelial cells, which are critically altered during chronic infections mediated by Pseudomonas aeruginosa, specifically express the inflammasome sensor NLRP1. Here, together with a companion study, we report that the NLRP1 inflammasome detects exotoxin A (EXOA), a ribotoxin released by P. aeruginosa type 2 secretion system (T2SS), during chronic infection. Mechanistically, EXOA-driven eukaryotic elongation factor 2 (EEF2) ribosylation and covalent inactivation promote ribotoxic stress and subsequent NLRP1 inflammasome activation, a process shared with other EEF2-inactivating toxins, diphtheria toxin and cholix toxin. Biochemically, irreversible EEF2 inactivation triggers ribosome stress–associated kinases ZAKα- and P38-dependent NLRP1 phosphorylation and subsequent proteasome-driven functional degradation. Finally, cystic fibrosis cells from patients exhibit exacerbated P38 activity and hypersensitivity to EXOA-induced ribotoxic stress–dependent NLRP1 inflammasome activation, a process inhibited by the use of ZAKα inhibitors. Altogether, our results show the importance of P. aeruginosa virulence factor EXOA at promoting NLRP1-dependent epithelial damage and identify ZAKα as a critical sensor of virulence-inactivated EEF2.